Tag Archives: Fighting Cancer

Living Healthy: Peanuts May Help Increase Longevity

Fighting Cancer With Peanuts
Fighting Cancer With Peanuts

An apple a day is said to keep the doctor away, and now it turns out adding a handful of peanuts to your daily diet could keep your funeral away to boot. How? A recent study has determined consuming peanuts and tree nuts daily is associated with a lower risk of dying over a 5-6 year period versus those who ate few or none. How “nuts” should you go? Issels® has the the 4-1-1 for helping you live a long, healthy life.

The nutty news…
The study, published in the journal JAMA Internal Medicine, linked consuming peanuts and tree nuts such as walnuts, pecans, and almonds with fewer deaths from heart-related issues, as well as fewer deaths overall. And you don’t need to munch predominately on costly kernels such as tree nuts either. Peanuts, a far more affordable option to tree nuts, offers similar cardiovascular benefits for far less cost.

Go nuts. Peanuts that is.
As long as you’re not allergic, consuming these lucky legumes can increase your longevity by 21 percent over nut naysayers. These benefits were seen with the consumption of about 2/3 of one ounce, or 17-18 grams. Even better? The findings held true regardless of smoking, drinking, body mass, and metabolic condition.

What’s in a nut?
Peanuts are nutrient rich, packed with unsaturated fats, fiber, antioxidants, and vitamins. It’s theorized the goodies packed in plant-based peanuts could help maintain the heart’s endothelial function, and consequently cell-lining blood vessels. This in addition to the nut’s heart-healthy antioxidant and anti-inflammatory effects.

Is your health making you nutty? Issels® can help. Contact us today to learn more about our proven immunotherapy cancer treatment options today.

Dr. Josef Issels: Highlighting Our History

Issels
Ilse Marie Issels, wife of Dr. Josef M. Issels

When you visit an Issels® Integrative Immuno-Oncology clinic for cancer treatment, you receive the benefit of our long history of remission success using immunotherapy protocols. Our founder, Dr. Josef M. Issels, was a pioneer in the field of non-toxic cancer immunotherapy and Mrs. Ilse Marie Issels and their sons are proud to carry on his legacy.

Dr. Issels began the first hospital in the world dedicated to integrative immunotherapy now more commonly known as Immuno-Oncology – in his homeland of Germany. The 120-bed facility focused on patients with advanced cancers, many of whom had failed to improve their prognosis with conventional treatments.

Vaccines from the patient’s own blood and other Innovative methods developed by Dr. Issels treated the tumor, and with the same importance, its microenvironment, which includes the extracellular matrix, the blood vessels, immune cells and signaling molecules. This concept created controversy in some medical circles at the time, but research today has confirmed the importance of the microenvironment in the progression or regression of tumors.

In 1981, thanks to his extensive knowledge and outstanding success, Dr. Issels was asked to serve as a member of the German Federal Government Commission in the Fight Against Cancer. He remained on the commission until his retirement in 1987, when he brought his integrative immuno-oncology practice to the United States.

After Dr. Issels passed away in 1998, his work was continued by Ilse Marie Issels, his wife and collaborator of 40 years. She was joined by their sons, Dr. Christian N. Issels and Hellmut J. Issels. Today the Issels team, of 8 doctors at the inpatient and outpatient facilities, collaborates under the leadership of Dr. Christian N. Issels and maintains the same high standards and tireless commitment of their late founder.

We continue to treat our patients with the latest non-toxic immunobiologic cancer therapies at the Issels clinics in North America. Visit our website to learn more about what makes Issels® a leader in personalized integrative Immuno-Oncology methods.

Can a New Trial Crack Open the Secret Weak Spot of Cancer Tumors?

Finding The Weak Spot
Finding The Weak Spot

At Issels® we are always looking for ways to improve outcomes for patients whose cancer has resisted standard therapies. One recent development to watch is tumor profiling. These specialized tests analyze the genetic makeup of a tumor and may be the key for doctors to determine if another, less obvious treatment option might help.

A few recent trials have studied the results of alternative drugs that were assigned based on the results of tumor profile tests. So far, the results are very encouraging for people whose cancer has resisted initial chemotherapy or other standard treatment.

Here’s how tumor profiling can unveil the mystery of why a cancer medicine has failed:

  • The genetic testing looks for mutations present in the tumor cells.
  • Mutations are often found that have more in common with an unrelated form of cancer; for example, a colon cancer tumor could have a mutation common in breast cancer.
  • Doctors then provide treatment on a trial basis to see if the patient’s condition can be improved by a drug known to defeat the other form of cancer.

The trials have examined results in patients who had already tried other treatment options. In many cases, the metastatic cancer stopped growing or even shrunk.

One trial saw positive results in 40% of its 25 patient test group. Another trial found improvement in all 6 patients who received alternative therapies based on tumor profiling.

Seen as part of a trend toward individualized cancer treatments, these new advances place a focus on treating the patient’s disease at the genetic and cellular levels after standard therapies have failed.

To find out more about gene-targeted therapies and cell therapies, please contact us at Issels® Integrative Immuno-Oncology.

What Are Probiotics? How Can They Help Me?

Get Your Probiotics
Get Your Probiotics

Living healthy. This is something we see, hear, and read about on a daily basis. For many, healthy living is a choice, for many others, it’s necessary due to health issues. Either way, living a healthy lifestyle is a positive goal to focus on. At Issels ®, we focus on providing you with the help and support you need to live healthy including nutritional tips for cancer patients.

Another word you might have heard in the world of health is “probiotics.” These friendly bacteria and yeasts are good for the digestive system. They’re found in the digestive system and in certain foods such as yogurt, honey, cheese, oats, and pickles. There are also over-the-counter supplements for these friendly bacteria.

Benefits of probiotics include:

  • When your body loses bacteria, probiotics serve as a replacement
  • Probiotics keep bad bacteria that can lead to infections at low levels
  • Probiotics work as a monitor to keep good bacteria and bad bacteria balanced

For patients who are going through cancer treatment as well those who have completed treatment, studies show certain probiotic strains help reduce issues of diarrhea due to radiation treatment.

According to an article by Vanessa Wada, MS, RD, studies indicate,”these organisms have demonstrated their potential in minimizing cancer treatment side effects and reducing cancer risk.” That is encouraging.

Her report also notes liver cancer may also be affected by probiotics as well as breast cancer and bladder cancer. As positive research continues into the healthy effects of the bacteria, Dr. Wada suggests adding probiotics to the diet.

If you have questions or need information, contact our staff at Issels in the USA, Canada or abroad by phone. Or use our convenient online form and we’ll respond to your email.

TGen Study Looks at Cancer Tumor Cloaking Materials

image of cells
Tripping Down To The Cancer

Treating cancer is difficult enough without the cancer cells hiding behind an extra layer of cellular material called stroma. Researchers at Translational Genomics Research Institute (TGen) believe drugs that strip away that stroma could improve the effectiveness of cancer drugs. At Issels® Integrative Immuno-Oncology, we understand complexities of effective cancer treatment. That is why our personalized, non-toxic treatments are based on extensive clinical and scientific research.

The TGen study

The TGen researchers state that breaking down that stroma could significantly extend the life of cancer patients, even those with late stage cancer that has already spread to some of their other organs. The stroma is made up of hyaluronan and various other types of collagen. It impedes anti-cancer drugs from finding their targeted cancer cells. The TGen researchers noticed a correlation between higher levels stroma and poor survival rates among patients with pancreatic cancer.

Pancreatic cancer

The pancreas is located behind the stomach. It is responsible for producing essential digestive juices and other necessary hormones. Each year, approximately 49,000 people in the U.S. are diagnosed with pancreatic cancer. Over 40,000 will die, making it the fourth deadliest cancer in America. The median survival time for people with advanced pancreatic cancer is 6 months from diagnosis. Less than six percent live five or more years after the diagnosis.

Dr. Daniel D. Von Hoff, who authored the TGen study, believes therapies that target stroma could lead to much better survival rates.

We want to keep you updated on the latest cancer research and provide the information you need to make informed decisions about your cancer treatment. Visit the Issels® website and sign up for our free e-Newsletter.

The Realities of Living with Stage 4 Breast Cancer

Breast Cancer Awareness
Stage 4 Breast Cancer

While organizations like Susan G. Komen have promoted the importance of early detection in defeating breast cancer, there is another group that struggles to be heard. Women with Stage 4 metastatic breast cancer (MBC) are working to educate the public about the realities of living with what they refer to as “mets”.

Treating MBC

Cancer becomes metastatic when it travels through the blood to create tumors in the lungs, liver and other parts of the body. Between 20 and 30 percent of women who are diagnosed with early stage breast cancer will develop MBC, which is treatable but not curable.

Jody Schoger, an MBC patient and cancer awareness advocate, explains the difference in philosophy for treating both types. She says that when she received her initial diagnosis, her doctors pulled out all the stops in an attempt to put the tumor in permanent remission. With MBC, however, the best they can hope for is to stabilize the disease so they use a minimum of treatment needed to obtain the maximum effect.

Misconceptions about MBC

Women with MBC are frustrated that the focus on “survivorship” has resulted in a number of erroneous concepts about the disease. Pfizer Oncology surveyed 2,000 people on the topic and found that 60 percent of respondents knew little to nothing about MBC and 50 percent believed that it was a result of patients not taking care of themselves.

At Issels® we see you as an individual, not as your disease. Our treatments are personalized to address your particular needs. Contact us to learn more about our non-toxic alternative treatment program.